Price movement over the last 24 hours
AFLAC Incorporated vs Progressive Corp — how do they compare? AFLAC Incorporated trades at $121.38 (market cap $61.84B), while Progressive Corp trades at $235.97 (market cap $136.47B). The key difference: Progressive Corp is far larger — about 2.2× AFLAC Incorporated's market cap, and Progressive Corp pays the higher dividend (5.93%). Which is the better fit depends on your goals.
| AFL | PGR | |
|---|---|---|
Market Cap | $61.84B | $136.47B |
Sector | Financials | Financials |
52-Week High | $121.49 | $252.68 |
52-Week Low | $98.09 | $190.40 |
Enterprise Value | $70.50B | $144.69B |
Dividend Yield | 2.01% | 5.93% |
Signals from Pluang's Aura AI — not financial advice
Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.
The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.
Progressive (PGR) trades at $234.40, up 0.94% with a bullish technical signal and strong fundamentals. Recent earnings beat expectations with Q1 2026 EPS of $4.96 versus $4.85 estimate, continuing a trend of operational strength. Revenue grew to $87.64B in 2025 with net income margin at 12.93%, while analyst consensus price target is $235.67. The stock shows resilience with positive media coverage highlighting earnings growth and leadership changes.
Outlook remains positive driven by earnings momentum and scale advantages in auto insurance. Key risks include competitive pressures and macroeconomic sensitivity. Institutional sentiment is mixed with 41.46% buy ratings, but the stock's valuation at P/E 11.78 offers room for upside if earnings trends persist.
Trailing returns across standard periods
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →